# Direct Rx – FDA Inspection, Dec 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/direct-rx/2ec76038-0038-4123-ab24-dcdb74883444
Source feed: FDA_Inspections

> FDA inspection 1034986 of Direct Rx, December 15, 2017. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034986
- Company Name: Direct Rx
- Inspection Date: 2017-12-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1324204 - 2026-06-04
- [FDA Inspection 941193 - 2015-08-13](https://www.keypedia.com/records/fda_inspections/direct-rx/65e13496-acbd-4ade-8392-0303931af198)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gideon-n-esuzor/78dae9f4-77e9-469b-982d-2d4a42cc641f)

Company: https://www.keypedia.com/companies/direct-rx/5e5810ff-bb20-457b-8373-1218223a344f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c